Natco Pharma's marketing partner gets USFDA approval for chest pain tablets - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Natco Pharma's marketing partner gets USFDA approval for chest pain tablets

Nitroglycerin Sublingual Tablets had total annual sales of around USD 77.3 million.

from Stocks-Markets-Economic Times
Read The Rest:economictimes...

Post Top Ad